IRF4 and plasma cell myeloma: CD86 overexpression induces molecular changes such as increased expression of integrin ß1 and ß7 and interferon regulatory factor 4 (IRF4), a transcription factor necessary for myeloma survival which directly targets MYC (89, 172).